Atovaquone/proguanil resistance in Africa: a case report

Research output: Contribution to journalJournal articleResearchpeer-review

The Atovaquone/proguanil combination has quickly been established as an effective chemoprophylaxis for travellers to areas with chloroquineresistant Plasmodium falciparum malaria. We describe the molecular cause of the first reported case of primary Atovaquone/proguanil resistance observed in our department in a Plasmodium falciparum infected traveller returning from West Africa, and link our findings to other reports of resistance.
Original languageEnglish
JournalScandinavian Journal of Infectious Diseases
Volume35
Issue number11-12
Pages (from-to)897-8
Number of pages1
ISSN0036-5548
Publication statusPublished - 2003

Bibliographical note

Keywords: Adult; Africa; Animals; Atovaquone; Bacterial Proteins; Chloroguanide; Cytochrome b Group; Denmark; Drug Resistance, Multiple; Drug Therapy, Combination; Ferritins; Humans; Malaria, Falciparum; Male; Microbial Sensitivity Tests; Mutation; Naphthoquinones; Pharmacogenetics; Plasmodium falciparum; Polymerase Chain Reaction; Risk Assessment; Travel; Treatment Failure

ID: 17656922